Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000921895-10-001596
Filing Date
2010-10-29
Accepted
2010-10-29 20:20:46
Documents
1
Period of Report
2010-10-27

Document Format Files

Seq Description Document Type Size
1 form404197045_10292010.html 4  
1 form404197045_10292010.xml 4 6599
  Complete submission text file 0000921895-10-001596.txt   9144
Mailing Address C/O STEEL PARTNERS II L P 590 MADISON AVENUE, 32ND FLOOR NEW YORK NY 10022
Business Address
LICHTENSTEIN WARREN G (Reporting) CIK: 0001005784 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-23317 | Film No.: 101153238

Mailing Address ONE MAIN STREET SUITE 300 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 300 CAMBRIDGE MA 02142 6176492001
ORE PHARMACEUTICAL HOLDINGS INC. (Issuer) CIK: 0001043914 (see all company filings)

EIN.: 061411336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 590 MADISON AVENUE, 32ND FLOOR NEW YORK NY 10022
Business Address 590 MADISON AVENUE, 32ND FLOOR NEW YORK NY 10022 212-520-2300
Steel Partners, Ltd. (Reporting) CIK: 0001504325 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23317 | Film No.: 101153239